25 related articles for article (PubMed ID: 8695719)
1. Constructing training set using distance between learnt graphical models of time series data on patient physiology, to predict disease scores.
Chakrabarty D; Wang K; Roy G; Bhojgaria A; Zhang C; Pavlu J; Chakrabartty J
PLoS One; 2023; 18(10):e0292404. PubMed ID: 37856497
[TBL] [Abstract][Full Text] [Related]
2. Serum procollagen type III is an early and sensitive marker for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
Heikinheimo M; Halila R; Fasth A
Blood; 1994 May; 83(10):3036-40. PubMed ID: 8180401
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen.
Eltumi M; Trivedi P; Hobbs JR; Portmann B; Cheeseman P; Downie C; Risteli J; Risteli L; Mowat AP
Lancet; 1993 Aug; 342(8870):518-21. PubMed ID: 8102667
[TBL] [Abstract][Full Text] [Related]
4. Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation.
Salat C; Holler E; Wolf C; Kolb HJ; Reinhardt B; Pihusch R; Krämling HJ; Heinemann V; Haller M; Hiller E
Bone Marrow Transplant; 1997 Mar; 19(5):487-90. PubMed ID: 9052916
[TBL] [Abstract][Full Text] [Related]
5. N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin.
Rio B; Bauduer F; Arrago JP; Zittoun R
Bone Marrow Transplant; 1993 Jun; 11(6):471-2. PubMed ID: 8334428
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of veno-occlusive disease after bone-marrow transplantation by serum aminopropeptide of type III procollagen.
Yasutomo K; Himeno K
Lancet; 1993 Oct; 342(8878):1062. PubMed ID: 8105302
[No Abstract] [Full Text] [Related]
7. Evaluation of procollagen-III peptide as a marker for veno-occlusive disease after bone marrow transplantation.
Schuler U; Subat S; Schmidt H; Schneider A; Ehninger G
Ann Hematol; 1996 Jul; 73(1):25-8. PubMed ID: 8695719
[TBL] [Abstract][Full Text] [Related]
8. Hepatic veno-occlusive disease--liver toxicity syndrome after bone marrow transplantation.
Shulman HM; Hinterberger W
Bone Marrow Transplant; 1992 Sep; 10(3):197-214. PubMed ID: 1422475
[TBL] [Abstract][Full Text] [Related]
9. The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation.
Salat C; Holler E; Kolb HJ; Pihusch R; Reinhardt B; Penovici M; Ledderose G; Hiller E
Leuk Lymphoma; 1999 Mar; 33(1-2):25-32. PubMed ID: 10194118
[TBL] [Abstract][Full Text] [Related]
10. [Veno-occlusive disease of the liver].
Rybicka M; Krysiak R; Okopień B
Wiad Lek; 2009; 62(1):42-51. PubMed ID: 19817257
[TBL] [Abstract][Full Text] [Related]
11. Veno-occlusive disease of the liver after bone marrow transplantation: is hypercoagulability really part of the problem?
Korte W
Blood Coagul Fibrinolysis; 1997 Oct; 8(7):367-81. PubMed ID: 9391717
[TBL] [Abstract][Full Text] [Related]
12. Hepatobiliary disease after bone marrow transplant.
Dezan MGF; Cavalcante LN; Cotrim HP; Lyra AC
Expert Rev Gastroenterol Hepatol; 2023 Feb; 17(2):129-143. PubMed ID: 36655915
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
